Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
In the U.S., GLP-1 prescriptions more than doubled in just 18 months, topping nine million by early 2024
IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 with amino acid substitutions at positions 3 and extended half-life (2030 hours vs 10 minutes for endogenous IGF-1), enabling systemic anabolic signaling without growth hormone involvement
Why People Switch from Wegovy to Mounjaro for Weight Loss There are several personal and clinical reasons for moving from Wegovy (semaglutide) to Mounjaro (tirzepatide)
By slowing gastric emptying and enhancing feelings of fullness, it helps reduce overall caloric intake
)
![In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3944598823627244294)
